SyVento BioTech is thrilled to announce our participation in the BIO International Convention in San Diego, California, from June 3rd to 6th, 2024. This premier event, with over 20,000 industry leaders, offers an unparalleled opportunity to connect, collaborate, and propel the future of biotechnology.

Find Us at Booth 4049!

Our Chairman of Supervisory Board Tomasz Piec, CTO Dominik Lipka, PhD Eng., and our Business Development Managers Filip Zdrodowski and Maciej Boruczkowski will be showcasing our comprehensive services in the development of lipid-based nanocarriers and LNP technology.

Here’s how we can support your projects:

  • CDMO Expertise: We’re your one-stop shop for mRNA therapeutics, offering LNP formulation development, mRNA synthesis (including R&D and GMP grades), and fill & finish services.
  • Platform Solutions: Discover our advanced platforms for developing and delivering therapeutic molecules (small moleculesRNA, DNA, CRISPR, proteins).
      • Genetic Platform: High-quality mRNA synthesis and capping, optimized for therapeutic and prophylactic protein production. Our state-of-the-art approach ensures maximum mRNA stability and effective translation.
      • Delivery Platform: LNP and liposomal formulation development, along with the potential transfer of technology to the client, in the full scope: from preclinical research through the scale-up process to stability studies.
      • Manufacturing Platform: Production of LNP/liposomal batches for all clinical trial phases. We provide filling services for both customer-supplied and in-house produced forms.
      • Drug Development Expertise: Comprehensive analytical and regulatory services to support your projects, including development phase, preclinical research, batch preparation for clinical trials, launching the product on the market based on CMC (Chemistry Manufacturing Control) process.

      Follow us on X and LinkedIn for more updated content!